State Ledger
Company profile

UNITED THERAPEUTICS Corp CIK 1082554

Ticker
UTHR (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Silver Spring, MD 20910
Fiscal year end
2025 (FY)
Market Data
Close
$549.58
Change
+$0.26
Change %
0.05%
Volume
32,930

UTHR · trading date Oct 12, 2026 · previous close $549.32 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$3.18B
Net income
$1.33B
Total assets
$7.88B
Total liabilities
$783.80M
Stockholders' equity
$7.10B
Cash & equivalents
$1.56B
Operating income
$1.49B
Operating cash flow
$1.56B
Capital expenditures
$520.50M

Fiscal year 2025, via 10-K filed 2026-02-25. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
46.9%
Net margin
41.9%
Free cash flow
$1.04B
Free cash flow margin
32.7%
Liabilities / assets
9.9%
Equity / assets
90.1%
CapEx / revenue
16.4%
Operating cash flow / net income
1.17×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $3.18B $1.33B $7.88B $783.80M $7.10B
2024 $2.88B $1.20B $7.36B $920.00M $6.44B
2023 $2.33B $984.80M $7.17B $1.18B $5.98B
2022 $1.94B $727.30M $6.04B $1.25B $4.80B
2021 $1.69B $475.80M $5.17B $1.21B $3.96B
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-18
Financials filed via
Form 10-K
filed 2026-02-25

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Silver Spring, MD 20910
1000 SPRING ST
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:32 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Maryland — Public Companies